Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

786
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
786
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

420
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
420
Neural Regulation01:37

Neural Regulation

40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Huachansu triggers mitochondrial apoptosis and ER stress to inhibit hepatocellular carcinoma progression.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society·2026
Same author

Dystrophic changes of nigrostriatal axons harboring a Synj1 Parkinson mutation suggest catastrophic failure of endocytic mechanisms.

bioRxiv : the preprint server for biology·2026
Same author

Xianlian Jiedu Decoction induces apoptosis in colorectal cancer via modulation of sphingosine-1-phosphate-dependent JNK/p38 MAPK signaling.

Journal of ethnopharmacology·2026
Same author

Unveiling medication patterns in traditional Chinese medicine for the prevention of colorectal cancer recurrence: from potential combinations to validation of components and targets.

Chinese medicine·2026
Same author

Microglial sTREM2 limits dyskinesia and acts on TrkB to support circuit plasticity.

bioRxiv : the preprint server for biology·2026
Same author

Cell- and state-specific plasticity of striatal glutamatergic synapses is critical to the expression of levodopa-induced dyskinesia.

Neuron·2026

Related Experiment Video

Updated: Sep 30, 2025

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

6.3K

Striatal synaptic adaptations in Parkinson's disease.

Weixing Shen1, Shenyu Zhai1, D James Surmeier1

  • 1Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, United States of America.

Neurobiology of Disease
|March 10, 2022
PubMed
Summary

Parkinson's disease (PD) involves dopamine loss in the striatum, affecting movement. Adaptations in striatal cells and circuits influence levodopa treatment efficacy and side effects like dyskinesia.

Keywords:
Cholinergic interneuronHomeostasisLevodopa-induced dyskinesiaLow threshold spike interneuronSpiny projection neuronSynaptic plasticityThalamic input

More Related Videos

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.8K
Primary Culture of Mouse Dopaminergic Neurons
11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

38.4K

Related Experiment Videos

Last Updated: Sep 30, 2025

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

6.3K
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.8K
Primary Culture of Mouse Dopaminergic Neurons
11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

38.4K

Area of Science:

  • Neuroscience
  • Neurodegenerative Diseases
  • Motor Control

Background:

  • Parkinson's disease (PD) is characterized by progressive loss of dopaminergic neurons innervating the striatum.
  • Dopaminergic signaling modulates goal-directed actions and habit formation.
  • Levodopa therapy, while initially effective, can lead to debilitating dyskinesia in later stages of PD.

Purpose of the Study:

  • To review recent advances in understanding striatal cell and circuit adaptations to dopamine depletion and levodopa therapy in Parkinson's disease.
  • To explore how these adaptations contribute to motor deficits and treatment side effects.

Main Methods:

  • Review of recent scientific literature on striatal adaptations in Parkinson's disease.
  • Discussion of findings from studies on cell type-specific changes in spiny projection neurons (SPNs).
  • Examination of the roles of interneurons and ensemble dynamics in freely moving mouse models.

Main Results:

  • Dopamine depletion induces homeostatic changes in SPNs, normalizing activity but disrupting synaptic architecture.
  • Cholinergic and nitric oxide-releasing interneurons play significant roles in striatal adaptations.
  • Alterations in the spatiotemporal dynamics of striatal ensembles contribute to PD motor deficits.
  • Striatal pathway imbalance is necessary but not sufficient for frank parkinsonism.

Conclusions:

  • Striatal adaptations to dopamine loss are complex, involving multiple cell types and circuit dynamics.
  • Understanding these adaptations is crucial for developing more effective Parkinson's disease therapies.
  • The classical model of striatal pathway imbalance in PD requires refinement based on recent findings.